help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burghen, G. A.
Right arrow Articles by Kitabchi, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burghen, G. A.
Right arrow Articles by Kitabchi, A. E.

Journal of Clinical Endocrinology & Metabolism, Vol 50, 113-116, Copyright © 1980 by Endocrine Society

ARTICLES

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

GA Burghen, JR Givens and AE Kitabchi

We evaluated basal plasma total immunoreactive insulin (insulin), androstenedione, and testosterone in 14 obese women: 8 with polycystic ovarian disease (PCOD) and 6 obese controls. All 3 hormones were significantly elevated (P less than 0.02 to P less than 0.001) in PCOD patients. A significant correlation among basal levels of plasma insulin, androstenedione, and testosterone was demonstrated. The PCOD group had significantly higher levels of glucose at 1, 2, and 3 h, with similar significant increases in plasma insulin levels at 0, 2, and 3 h. A significant correlation was found between plasma insulin response areas and plasma testosterone (P less than 0.001) in the control and PCOD patients. These studies demonstrate that hyperandrogenism correlates with hyperinsulinism.


This article has been cited by other articles:


Home page
 Hum ReprodHome page
P. F. Svendsen, L. Nilas, K. Norgaard, J.-E. B. Jensen, and S. Madsbad
Obesity, body composition and metabolic disturbances in polycystic ovary syndrome
Hum. Reprod., June 12, 2008; (2008) den211v1.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. K. BLANK, K. D. HELM, C. R. MCCARTNEY, and J. C. MARSHALL
Polycystic Ovary Syndrome in Adolescence
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 76 - 84.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Yahyaoui, I. Esteva, J. J. Haro-Mora, M. C. Almaraz, S. Morcillo, G. Rojo-Martinez, J. Martinez, J. M. Gomez-Zumaquero, I. Gonzalez, V. Hernando, et al.
Effect of Long-Term Administration of Cross-Sex Hormone Therapy on Serum and Urinary Uric Acid in Transsexual Persons
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2230 - 2233.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
S. Chakrabarty and M. Nagamani
Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries
Reproductive Sciences, March 1, 2008; 15(3): 274 - 284.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
X. Ma, L. Fan, Y. Meng, Z. Hou, Y.-D. Mao, W. Wang, W. Ding, and J.-Y. Liu
Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome
Mol. Hum. Reprod., August 1, 2007; 13(8): 527 - 535.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, L.-T. Ho, Y.-P. Hsu, Y.-H. Lin, L.-W. Huang, and J.-L. Hwang
Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome
Hum. Reprod., April 1, 2007; 22(4): 1100 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
X. Chen, D. Yang, L. Li, S. Feng, and L. Wang
Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome
Hum. Reprod., August 1, 2006; 21(8): 2027 - 2032.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Mohlig, A. Jurgens, J. Spranger, K. Hoffmann, M. O Weickert, H. W Schlosser, T. Schill, G. Brabant, A. Schuring, A. F H Pfeiffer, et al.
The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome.
Eur. J. Endocrinol., July 1, 2006; 155(1): 127 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Rautio, J.S. Tapanainen, A. Ruokonen, and L.C. Morin-Papunen
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study
Hum. Reprod., June 1, 2006; 21(6): 1400 - 1407.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. Kwintkiewicz, R. Z. Spaczynski, N. Foyouzi, T. Pehlivan, and A. J. Duleba
Insulin and Oxidative Stress Modulate Proliferation of Rat Ovarian Theca-Interstitial Cells Through Diverse Signal Transduction Pathways
Biol Reprod, June 1, 2006; 74(6): 1034 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Topcu, M. Caliskan, E. E. Ozcimen, D. Tok, A. Uckuyu, D. Erdogan, H. Gullu, A. Yildirir, H. Zeyneloglu, and H. Muderrisoglu
Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?
Hum. Reprod., April 1, 2006; 21(4): 930 - 935.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F Gonzalez, N S Rote, J Minium, and J P Kirwan
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-{alpha} release in obese women with polycystic ovary syndrome.
J. Endocrinol., March 1, 2006; 188(3): 521 - 529.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Eisenhardt, N. Schwarzmann, V. Henschel, A. Germeyer, M. von Wolff, A. Hamann, and T. Strowitzki
Early Effects of Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 946 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
S. Chakrabarty, B. T. Miller, T. J. Collins, and M. Nagamani
Ovarian Dysfunction in Peripubertal Hyperinsulinemia
Reproductive Sciences, February 1, 2006; 13(2): 122 - 129.
[Abstract] [PDF]

Home page
 Eur J EndocrinolHome page
E. Lystedt, H. Westergren, J. Brynhildsen, L. Lindh-Astrand, J. Gustavsson, F. H Nystrom, M. Hammar, and P. Stralfors
Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness
Eur. J. Endocrinol., December 1, 2005; 153(6): 831 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Urbanek, A. Woodroffe, K. G. Ewens, E. Diamanti-Kandarakis, R. S. Legro, J. F. Strauss III, A. Dunaif, and R. S. Spielman
Candidate Gene Region for Polycystic Ovary Syndrome on Chromosome 19p13.2
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6623 - 6629.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. Diamanti-Kandarakis and C. Piperi
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Hum. Reprod. Update, November 1, 2005; 11(6): 631 - 643.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Gonzalez, J. Minium, N. S. Rote, and J. P. Kirwan
Hyperglycemia Alters Tumor Necrosis Factor-{alpha} Release from Mononuclear Cells in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5336 - 5342.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.A.A. Penna, P.R.B. Canella, R.M. Reis, M.F. Silva de Sa, and R.A. Ferriani
Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study
Hum. Reprod., September 1, 2005; 20(9): 2396 - 2401.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Ortega-Gonzalez, S. Luna, L. Hernandez, G. Crespo, P. Aguayo, G. Arteaga-Troncoso, and A. Parra
Responses of Serum Androgen and Insulin Resistance to Metformin and Pioglitazone in Obese, Insulin-Resistant Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1360 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Volpi, S. A. Lieberman, D. M. Ferrer, C. R. Gilkison, B. B. Rasmussen, M. Nagamani, and R. J. Urban
The Relationships Between Testosterone, Body Composition, and Insulin Resistance: A lesson from a case of extreme hyperandrogenism
Diabetes Care, February 1, 2005; 28(2): 429 - 432.
[Full Text] [PDF]

Home page
 J EndocrinolHome page
C Ortega-Gonzalez, L Cardoza, B Coutino, R Hidalgo, G Arteaga-Troncoso, and A Parra
Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome
J. Endocrinol., January 1, 2005; 184(1): 233 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, Y.-P. Hsu, L.-T. Ho, Y.-Y. Wang, and J.-L. Hwang
Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles
Hum. Reprod., January 1, 2005; 20(1): 117 - 121.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Mioni, S. Chiarelli, N. Xamin, L. Zuliani, M. Granzotto, B. Mozzanega, P. Maffei, C. Martini, S. Blandamura, N. Sicolo, et al.
Evidence for the Presence of Glucose Transporter 4 in the Endometrium and Its Regulation in Polycystic Ovary Syndrome Patients
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4089 - 4096.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A.J. Duleba, N. Foyouzi, M. Karaca, T. Pehlivan, J. Kwintkiewicz, and H.R. Behrman
Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress
Hum. Reprod., July 1, 2004; 19(7): 1519 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang
Improving reproductive performance in overweight/obese women with effective weight management
Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Cibula
Is insulin resistance an essential component of PCOS?: The influence of confounding factors
Hum. Reprod., April 1, 2004; 19(4): 757 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, L.-Y. Wu, Y.-P. Hsu, W.-M. Yang, Y.-L. Tsai, J.-L. Hwang, and L.-T. Ho
Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance
Hum. Reprod., January 1, 2004; 19(1): 48 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. De Leo, A. la Marca, and F. Petraglia
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Endocr. Rev., October 1, 2003; 24(5): 633 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, and J. S. Tapanainen
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4649 - 4654.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Haakova, D. Cibula, K. Rezabek, M. Hill, M. Fanta, and J. Zivny
Pregnancy outcome in women with PCOS and in controls matched by age and weight
Hum. Reprod., July 1, 2003; 18(7): 1438 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. S. Legro
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
Endocr. Rev., June 1, 2003; 24(3): 302 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Tafeit, R. Moller, S. Rackl, A. Giuliani, W. Urdl, U. Freytag, K. Crailsheim, K. Sudi, and R. Horejsi
Subcutaneous Adipose Tissue Pattern in Lean and Obese Women with Polycystic Ovary Syndrome
Experimental Biology and Medicine, June 1, 2003; 228(6): 710 - 716.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, I. Vauhkonen, R. Koivunen, A. Ruokonen, H. Martikainen, and J. S. Tapanainen
Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 148 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. Kaaks, A. Lukanova, and M. S. Kurzer
Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Bagis, A. Gokcel, H. B. Zeyneloglu, E. Tarim, E. B. Kilicdag, and B. Haydardedeoglu
The Effects of Short-Term Medroxyprogesterone Acetate and Micronized Progesterone on Glucose Metabolism and Lipid Profiles in Patients with Polycystic Ovary Syndrome: A Prospective Randomized Study
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4536 - 4540.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. B. Seminara and W. F. Crowley Jr.
Genetic Approaches to Unraveling Reproductive Disorders: Examples of Bedside to Bench Research in the Genomic Era
Endocr. Rev., June 1, 2002; 23(3): 382 - 392.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
R. KAAKS and A. LUKANOVA
Effects of Weight Control and Physical Activity in Cancer Prevention: Role of Endogenous Hormone Metabolism
Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 268 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Homburg
Should patients with polycystic ovarian syndrome be treated with metformin?: A note of cautious optimism
Hum. Reprod., April 1, 2002; 17(4): 853 - 856.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard
Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study
Diabetes Care, January 1, 2002; 25(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. M. Koivunen, L. C. Morin-Papunen, A. Ruokonen, J. S. Tapanainen, and H. K. Martikainen
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin
Hum. Reprod., December 1, 2001; 16(12): 2546 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, A. E. Calogero, M. Farina, V. De Leo, A. La Marca, and A. Cianci
Clinical, endocrine and metabolic effects of acarbose, an {alpha}-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
Hum. Reprod., October 1, 2001; 16(10): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. J. Duleba, T. Pehlivan, R. Carbone, and R. Z. Spaczynski
Activin Stimulates Proliferation of Rat Ovarian Thecal-Interstitial Cells
Biol Reprod, September 1, 2001; 65(3): 704 - 709.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
E. Shalev, S. Goldman, and I. Ben-Shlomo
The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women
Mol. Hum. Reprod., April 1, 2001; 7(4): 325 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. M. Martens, D. H. Geller, W. Arlt, R. J. Auchus, V. S. Ossovskaya, H. Rodriguez, A. Dunaif, and W. L. Miller
Enzymatic Activities of P450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4338 - 4346.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, H. K. Martikainen, and J. S. Tapanainen
Endocrine and Metabolic Effects of Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3161 - 3168.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
P. J. Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action in hypogonadotrophic hypogonadism
Hum. Reprod., August 1, 2000; 15(8): 1672 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. A. Lobo and E. Carmina
The Importance of Diagnosing the Polycystic Ovary Syndrome
Ann Intern Med, June 20, 2000; 132(12): 989 - 993.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.D. Murray, R.M. Davison, R.C. Russell, and G.S. Conway
Clinical presentation of PCOS following development of an insulinoma: Case Report
Hum. Reprod., January 1, 2000; 15(1): 86 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, V. De Leo, F. Galvani, A. La Marca, and A. Cianci
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
Hum. Reprod., December 1, 1999; 14(12): 2951 - 2958.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Lemieux, G. F. Lewis, A. Ben-Chetrit, G. Steiner, and E. M. Greenblatt
Correction of Hyperandrogenemia by Laparoscopic Ovarian Cautery in Women with Polycystic Ovarian Syndrome Is Not Accompanied by Improved Insulin Sensitivity or Lipid-Lipoprotein Levels
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4278 - 4282.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
M.F.M. Mitwally, N.K. Kuscu, and T.M. Yalcinkaya
High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome
Hum. Reprod., November 1, 1999; 14(11): 2700 - 2703.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Wahrenberg, I. Ek, S. Reynisdottir, K. Carlström, A. Bergqvist, and P. Arner
Divergent Effects of Weight Reduction and Oral Anticonception Treatment on Adrenergic Lipolysis Regulation in Obese Women with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2182 - 2187.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
A.M. Fulghesu, F. Cucinelli, V. Pavone, F. Murgia, M. Guido, A. Caruso, S. Mancuso, and A. Lanzone
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome
Hum. Reprod., March 1, 1999; 14(3): 611 - 617.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 165 - 169.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. P. Diamond, D. Grainger, M. C. Diamond, R. S. Sherwin, and R. A. DeFronzo
Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4420 - 4425.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, D. Finegood, and A. Dunaif
A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2694 - 2698.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, A. Mitrakou, S. Raptis, G. Tolis, and A. J. Duleba
The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2699 - 2705.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev., December 1, 1997; 18(6): 774 - 800.
[Abstract] [Full Text]